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Vaginal probiotic 
may help in 
pregnancy
Microbiology researcher Nicole Jimenez is 
studying how bacteria in the vaginal canal can 
positively influence the growth of a healthy infant
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Consuming probiotics is a healthy fad that nutritionists and doctors are encouraging; 
eat enough, and your digestion will improve. 
However, millions of “good” bacteria live in us 
and perform healthy functions. Women, for 
example, have probiotics that originate in the 
vaginal canal. One particular kind of bacteria 
there may provide benefits during pregnancy.
Dr. Nicole Jimenez, a microbiology researcher 
at VCU, is experimenting with a microorganism 
called bifidobacteria in hopes that it might help 
us understand the development of the infant gut 
microbiome.
“I’m researching the role this species plays in 
the vaginal microbiome and how it may provide 
insight into infant gut development,” Jimenez 
said.
Studies have been performed on bifidobacterium 
breve, a species in the Bifidobacteriaceae family, 
but not many in the vaginal canal.
Bifidobacterium breve is found in gut, oral, 
human milk and vaginal microbiomes. Previous 
studies have examined the transmission of 
commensal bacteria. They show how microbial 
succession occurs within the gut microbiome 
of an infant via interaction with the mother’s 
microbiomes.
“B. breve is theorized to provide a protective 
role in the vaginal community as it has played a 
beneficial role in the gut microbiome,” Jimenez 
said.
Jimenez says researchers from the Vaginal 
Microbiome Consortium at the Medical College 
of Virginia collected samples from a group of 
women 18 and older. She helped select 12 
vaginal samples with assistance from the VCU 
Nucleic Acid Research Facility to find their 
genomic sequence. Jimenez is comparing these 
strains to B. breve genomic sequences from 
other areas: in human milk, the gut, the mouth 
and vaginal sites.
“For Aim #1, we focused on the Pan-
genome Analysis of Human Niche Specific 
Bifidobacterium breve strains,” Jimenez said. 
“We selected samples from women with no 
current gynecological diagnosis with a B. breve 
vagitype.”
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Dr. Jimenez is researching the role that bifidobacteria plays in the vaginal microbiome.
3
The Scope
Her research may provide insight into infant gut development. 
(Photo courtesy of Dr. Jimenez)
Dr. Jimenez says more extensive research will be done because 
she is still analyzing the data. (Photo courtesy of Dr. Jimenez)
Jimenez found that the genomic sequences 
of vaginal B. breve are similar to the genomic 
sequences of vaginal B. breve from other body 
sites. However, she says there is plenty more 
work to accomplish.
“For Aim #2, we wanted to understand the 
stability of B. breve in the vaginal microbiome 
over time – in this case, approximately one 
year,” Jimenez said.
“We selected paired vaginal samples from three 
women who completed two annual clinical exam 
visits approximately one year apart and who 
exhibited at least 25 percent abundance of B. 
breve in their vaginal microbiome at both visits. 
Half of these samples exhibited the B. breve 
vagitype of greater than 35 percent abundance, 
so three were [also] included in Aim #1.”
Jimenez says VCU’s Nucleic Acid Research 
Facility performed basic bacterial culturing 
techniques and genomic preparation for DNA 
sequencing.
Once Jimenez received the genomic sequence, 
she could begin identifying “genomic differences 
and metabolic differences between sequences 
either from different niche-strain isolates or 
different isolates from different time points.”
More extensive research will be done because 
she is still analyzing the data.
“My work is pertinent to the field because it adds 
more vaginal sequences for future comparative 
genomic work, since currently there is lack of 
vaginal Bifidobacterium sequences,” Jimenez 
said. •
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